Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 290

    1.

    Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study.

    Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, Howard BV; Strong Heart Study.

    Diabetes Care. 2003 Mar;26(3):861-7.PMID: 12610050 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study.

    Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M.

    Diabetes Care. 2007 Feb;30(2):318-24.PMID: 17259501 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

    Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M.

    Diabetes Care. 2002 Jul;25(7):1135-41.PMID: 12087010 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.

    Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW.

    Diabetes. 2005 Nov;54(11):3252-7.PMID: 16249452 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.

    Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G.

    Metabolism. 2006 Apr;55(4):445-52.PMID: 16546474 [PubMed - indexed for MEDLINE]Related articles

    7.

    Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.

    Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S.

    J Am Coll Cardiol. 2007 May 29;49(21):2112-9. Epub 2007 May 17.PMID: 17531661 [PubMed - indexed for MEDLINE]Related articles

    8.

    Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.

    Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB.

    J Clin Endocrinol Metab. 2006 Aug;91(8):2906-12. Epub 2006 May 30.PMID: 16735483 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.

    Hanley AJ, Williams K, Stern MP, Haffner SM.

    Diabetes Care. 2002 Jul;25(7):1177-84.PMID: 12087016 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.

    Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW.

    Diabetes Care. 2007 May;30(5):1219-25. Epub 2007 Jan 26.PMID: 17259468 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    J Clin Endocrinol Metab. 2003 Oct;88(10):4596-601.PMID: 14557428 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cardiometabolic risk among African American women: a pilot study.

    Appel SJ, Oster RA, Floyd NA, Ovalle F.

    J Cardiovasc Nurs. 2009 Mar-Apr;24(2):140-50.PMID: 19242280 [PubMed - indexed for MEDLINE]Related articles

    14.

    Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state.

    Gruber A, Horwood F, Sithole J, Ali NJ, Idris I.

    Cardiovasc Diabetol. 2006 Nov 1;5:22.PMID: 17078884 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.

    Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS.

    Metabolism. 2006 Nov;55(11):1551-7.PMID: 17046560 [PubMed - indexed for MEDLINE]Related articles

    16.

    LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study.

    Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welty TK, Go OT, Howard WJ.

    Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):830-5.PMID: 10712410 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.

    de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE; Strong Heart Study Investigators.

    Diabetes Care. 2007 Jul;30(7):1851-6. Epub 2007 Apr 17.PMID: 17440172 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.

    Jeppesen J, Hansen TW, Olsen MH, Rasmussen S, Ibsen H, Torp-Pedersen C, Hildebrandt PR, Madsbad S.

    Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):594-8.PMID: 18753952 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease.

    Rutter MK, Wilson PW, Sullivan LM, Fox CS, D'Agostino RB Sr, Meigs JB.

    Circulation. 2008 Feb 26;117(8):1003-9. Epub 2008 Feb 4.PMID: 18250267 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data